Veterinary Clinical Trials
A Global Strategic Business Report
MCP33250
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETINGHIGHLIGHTS & REPORT INDEX
Global Veterinary Clinical Trials Market to Reach US$7.6 Billion by 2030
The global market for Veterinary Clinical Trials estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Companion Animal, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Livestock Animal segment is estimated at 7.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.0% CAGR
The Veterinary Clinical Trials market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Global Veterinary Clinical Trials Market – Key Trends & Drivers Summarized
Why Are Veterinary Clinical Trials Gaining Prominence in Modern Animal Health Research?
Veterinary clinical trials are becoming an essential part of animal health innovation, driven by the growing demand for safe, effective, and evidence-based treatments in both companion and livestock animals. As veterinary medicine continues to evolve in complexity and sophistication—mirroring advancements in human healthcare—there is an increasing need to validate new drugs, vaccines, biologics, devices, and therapies through rigorous, structured clinical testing. These trials are critical for assessing efficacy, safety, dosing protocols, and potential side effects before commercial launch. The rise in chronic diseases, zoonotic threats, antimicrobial resistance, and age-related conditions among pets and farm animals is intensifying the pressure to bring new veterinary products to market. At the same time, pet owners and livestock producers alike are seeking improved treatment outcomes, leading to greater interest in precision veterinary medicine, personalized nutrition, and targeted therapeutics. This changing landscape has made veterinary clinical trials more relevant than ever, with a rising number of veterinary research organizations (CROs), academic institutions, pharmaceutical companies, and regulatory agencies placing strong emphasis on preclinical and clinical research that complies with global safety and ethical standards.
How Is Technology Enhancing the Design and Execution of Veterinary Trials?
Technological innovation is revolutionizing how veterinary clinical trials are designed, monitored, and analyzed—making them faster, more data-driven, and compliant with evolving regulations. Electronic data capture (EDC) systems and cloud-based trial management platforms are enabling real-time data collection, remote monitoring, and secure sharing between research sites, veterinarians, and sponsors. Wearable devices and sensor-based collars are now being used to gather continuous physiological data on animals during trials, such as heart rate, activity levels, and body temperature, providing richer insights without causing stress or requiring repeated clinic visits. AI and machine learning algorithms are being applied to analyze large datasets, identify trends, and improve patient recruitment by matching animals to relevant trials based on breed, age, condition, and location. Mobile apps and telemedicine tools are also supporting virtual consultations and at-home data collection, particularly in long-term chronic disease trials. These digital tools are helping streamline trial logistics, reduce human error, and improve participant retention, while also enhancing transparency for pet owners and farm managers. Overall, these technologies are not only optimizing the operational side of veterinary trials but are also raising the standard of scientific evidence generated in veterinary medicine.
Why Are Pharma Companies, CROs, and Veterinary Clinics Expanding Their Clinical Trial Activity?
Pharmaceutical companies, contract research organizations (CROs), and veterinary clinics are significantly expanding their investment in clinical trial infrastructure to meet growing regulatory demands and accelerate innovation in the veterinary therapeutics space. Animal health companies are increasingly focusing on developing specialized products for conditions like osteoarthritis, cancer, diabetes, dermatological disorders, and infectious diseases—areas that require rigorous clinical validation before entering the market. As the veterinary drug pipeline expands, CROs are partnering with veterinary practices and academic institutions to conduct multicenter trials that ensure data reliability and demographic diversity. Veterinary clinics—especially those affiliated with universities or large networks—are establishing research arms to enroll patients in trials, giving pet owners access to cutting-edge treatments while contributing to scientific advancement. Additionally, livestock producers and agribusiness stakeholders are working with animal health companies to test products that improve herd productivity, disease resistance, and food safety. Regulatory bodies such as the FDA (Center for Veterinary Medicine), EMA (CVMP), and other national authorities have strengthened guidance around Good Clinical Practice (GCP) for veterinary studies, which is increasing compliance costs but also professionalizing the entire ecosystem. This surge in collaborative, well-structured trial activity reflects a maturing market that is embracing data-backed innovation as the foundation of future animal health solutions.
What’s Driving the Global Growth of the Veterinary Clinical Trials Market?
The growth in the veterinary clinical trials market is driven by several interrelated factors tied to rising pet ownership, livestock health priorities, regulatory evolution, and technological advancement. One of the most significant drivers is the growing prevalence of chronic and lifestyle-related diseases in companion animals, which has increased demand for new treatment modalities and preventive solutions. Meanwhile, livestock health remains a high priority for ensuring global food security and sustainability, especially in the face of emerging diseases, climate change, and antibiotic resistance. The increasing willingness of pet owners to participate in clinical studies—fueled by better education, trust in veterinary science, and access to novel therapies—is improving recruitment and study success rates. At the same time, global harmonization of regulatory standards for veterinary products is encouraging pharmaceutical companies to invest in cross-border trials that facilitate faster approvals. The rise of veterinary-specific CROs and digital trial management tools is also improving trial scalability and efficiency, making research more accessible to clinics of all sizes. Additionally, the growth of pet insurance, specialty practices, and university-affiliated animal hospitals is creating more opportunities to conduct structured, large-scale research. These collective trends are turning veterinary clinical trials into a critical growth engine for the animal health industry, accelerating the delivery of innovative solutions for pets, livestock, and the veterinarians who care for them.
SCOPE OF STUDY
The report analyzes the Veterinary Clinical Trials market by the following Segments, and Geographic Regions/Countries:
Segments:
Animal (Companion Animal, Livestock Animal, Other Animals); Indication (Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, Other Indication); Intervention (Medicines, Medical Devices, Others); Sponsor (Pharma & Biopharma Companies, Academics & Research Centers, Others).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
AGLAIA; Animal Health Consultants; Argenta; Biotest Lab; Cebiphar; Charles River Laboratories; Clinvet; Cloudbyz; ERBC; IDEXX Laboratories; Inotiv; KLIFOVET GmbH; knoell; Labcorp Drug Development; Löhlein & Wolf Vet Research; Oncovet Clinical Research (OCR); Premier Research; QTest Labs; Scantox; STATKING Clinical Services
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Veterinary Clinical Trials – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 48 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Demand for Evidence-Based Veterinary Medicine Throws the Spotlight on Structured Clinical Research |
| Growth in Companion Animal Therapeutics Strengthens the Business Case for Expanded Trial Activity |
| Here`s How Emerging Zoonotic Diseases Are Driving Urgency in Vaccine and Drug Testing for Animal Health |
| Technological Advancements in Remote Monitoring and EDC Systems Accelerate Trial Efficiency and Data Accuracy |
| Expansion of Animal Oncology, Pain Management, and Chronic Disease Segments Spurs Growth in Therapeutic Studies |
| Rising Pet Owner Willingness to Enroll Animals in Trials Expands Participant Pools and Access to Innovation |
| Here`s the Story Behind AI and Big Data Enhancing Trial Design, Patient Matching, and Predictive Outcomes |
| Pharmaceutical Investment in Animal-Specific Drug Pipelines Fuels Demand for Clinical Validation Platforms |
| Integration of Biomarkers and Genetic Profiling Drives Precision Veterinary Trial Development |
| Globalization of Veterinary Pharma Markets Encourages Cross-Border Trial Collaborations and Knowledge Sharing |
| Growth of Telemedicine and At-Home Data Collection Tools Broadens Trial Accessibility and Real-World Evidence Capture |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Veterinary Clinical Trials Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Veterinary Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Companion Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Companion Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Companion Animal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Livestock Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Livestock Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Livestock Animal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Internal Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Internal Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Internal Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Interventions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Academics & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Academics & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Academics & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Sponsors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| JAPAN |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| CHINA |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| EUROPE |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Veterinary Clinical Trials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| FRANCE |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| GERMANY |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Veterinary Clinical Trials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| INDIA |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Veterinary Clinical Trials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Veterinary Clinical Trials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
| AFRICA |
| Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]